Embla Medical hf. (CPH:EMBLA)
Denmark · Delayed Price · Currency is DKK 32.60
0.00 (0.00%)
At close: Jan 16, 2026
Embla Medical Market Cap
Embla Medical has a market cap or net worth of 13.93 billion as of January 16, 2026. Its market cap has decreased by -6.50% in one year.
Market Cap
13.93B
Enterprise Value
16.88B
Revenue
5.71B
Ranking
n/a
PE Ratio
28.46
Stock Price
32.60
Market Cap Chart
Since September 4, 2009, Embla Medical's market cap has increased from 2.33B to 13.93B, an increase of 498.79%. That is a compound annual growth rate of 11.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 13.93B | 0.31% |
| Dec 30, 2025 | 13.89B | -8.62% |
| Dec 30, 2024 | 15.20B | 31.74% |
| Dec 29, 2023 | 11.54B | -18.15% |
| Dec 30, 2022 | 14.10B | -21.07% |
| Dec 30, 2021 | 17.86B | -12.64% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.73T |
| Genmab | 134.59B |
| Coloplast | 130.13B |
| Demant | 49.63B |
| ALK-Abelló | 49.55B |
| H. Lundbeck | 44.75B |
| Zealand Pharma | 29.55B |
| Ambu A/S | 24.40B |